Context Blood-based analytes may be indicators of pathological processes in Alzheimer
disease (AD). Objective To identify plasma proteins associated with AD pathology using a …

Background:As the population ages, it is increasingly important to use effective short cognitive
tests for suspected dementia. We aimed to review systematically brief cognitive tests for …

Background: Neuropsychiatric symptoms (NPS) in dementia have received much attention
due to their high prevalence and their significant implications. NPS in mild cognitive …

BackgroundDiabetes mellitus is associated with cognitive dysfunction, but it is not clear whether
the disorder increases the risk of conversion from mild cognitive impairment to dementia.…

Background Cannabinoid-based medicines (CBMs) are being used widely in the elderly.
However, their safety and tolerability in older adults remains unclear. We aimed to conduct a …

Late-onset Alzheimer’s disease is a prevalent age-related polygenic disease that accounts
for 50–70% of dementia cases. Currently, only a fraction of the genetic variants underlying …

Increased cerebrospinal fluid neurofilament light (NfL) is a recognized biomarker for
neurodegeneration that can also be assessed in blood. Here, we investigate plasma NfL as a …

Introduction The aim of this study was to (1) replicate previous associations between six blood
lipids and Alzheimer's disease (AD) (Proitsi et al 2015) and (2) identify novel associations …

Objective To assess the safety and feasibility of prescribing long term lithium to elderly people
with mild to moderate Alzheimer's disease (AD). Methods An open label treatment group …

Biomarkers for Alzheimer’s disease (AD) based on non-invasive methods are highly desirable
for diagnosis, disease progression, and monitoring therapeutics. We aimed to study the …